Charity Number 1003867
H. & M. CASTANG CHARITABLE TRUST
ANNUAL REPORT AND STATEMENT OF ACCOUNTS
FOR THE YEAR ENDED 5TH APRIL 2024
Gibbons Mannington & Phipps LLP Chartered Accountants 20 Eversley Road Bexhill-on-Sea East Sussex TN40 1HE
H. & M. CASTANG CHARITABLE TRUST CHARITY NUMBER 1003867 ANNUAL REPORT FOR THE YEAR ENDED 5[TH] APRIL 2024
Page 1.
The trustees present their report with the financial statements of the charity for the year ended 5[th] April 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015).
OBJECTIVES AND ACTIVITIES
Objectives and aims
The Trust is registered with the Charity Commission and was created by a Deed of Trust dated 12[th] July 1991 whereby Miss Hilda Castang settled funds on the Trustees (at that time herself, Michael Boyde Glynn and Ian Anthony Burman) to be used “for or towards such charitable purposes as the Trustees at their sole and absolute discretion think fit” (Clause 6.1).
The Settlor’s brother Max Castang, who had recently died, had suffered from Cerebral Palsy from birth and the Settlor wished particularly for the Charity to use its resources for “the promotion of research into the causes of and the alleviation of all forms of mental and physical handicap or disability and the publication of the useful results of such research and the relief of persons suffering from the same by the provision of financial assistance” (Clause 6.2(a)).
Initially, the Trustees used income to make grants to charities involved in caring for the mentally and physically disabled but as they became more aware of the problems involved it became clear that funding for research into the underlying causes of mental and physical disability was much needed.
To this end the Trustees have recruited individuals with medical knowledge to assist the Trustees deliberations.
The Trustees shall hold the capital and income of the Trust Fund upon trust to apply the income and all or such part or parts of the capital for or towards such charitable purposes as the Trustees at their sole and absolute discretion think fit, and in particular for the promotion for the public benefit of research into the causes and alleviation of neurodisability in childhood and publication of the useful results of such research.
Investment Policy
The Trust has power to invest in such assets as it sees fit. The Trust’s policy is to invest in a range of fixed interest stocks and equity shares and the portfolio is managed by Charles Stanley & Company Limited, the Trust’s stockbrokers. The Investments are held by ROCK (Nominees) Limited, Cofunds and Euroclear. The Trustees require a broad spread of investments, without restriction on the basis of ethical considerations, a low to medium risk to capital and an annual income of approximately £85,000. Approximately 96% of the income requirement has been met this year and a similar level is anticipated for 2024/25. The value of the investments has decreased by 7% in the year.
The Trust holds a variety of cash deposits to provide varying degrees of liquidity.
Grant Making Policy
The Trustees consider applications for grants at each meeting. Applications are submitted to the Foundation and if necessary are peer reviewed by a Trustee prior to the next meeting. The Trustees may request further information. The Foundation has also entered into a collaborative arrangement with the British Academy of Childhood Disability who put forward projects for the Foundation to support.
ACHIEVEMENTS AND PERFORMANCE
Charitable activities
The Trustees held two meetings in the year, on 17 May 2023 and 15 November 2023.
The Trustees reluctantly, and with the agreement of the British Academy of Childhood Disability (BACD), withdrew the grant offered to the team led by Sarah Martin-Denham at University of Sunderland to assess whether children identified in school census as having learning difficulties had appropriate paediatric clinical assessments. Little or no progress been made in the previous 12 months and the Trustees considered that the study was taking too long to get itself into a position to make any real progress.
The long standing BACD Funding Award sponsored by the Foundation on a study carried out at University of Birmingham led by Dr Caroline Richards on identifying young children at the highest risk for developing severe challenging behaviour resulted in the publication of two PhD dissertations on the results of the study.
The Foundation continues to work in partnership with the National Institute for Health Research co-funding the NIHR Castang Foundation Advanced Fellowship Award given to Dr Alexandra Hendry at the University of Oxford to fund research into “refining testing and targeting an intervention to support the early development of executive functions amongst infants at elevated likelihood of autism and/or ADHD” The total cost for this award over a period of five years is £190,101 and in the year to 5 April 2024 the Trustees had paid £40,069 of this.
H. & M. CASTANG CHARITABLE TRUST CHARITY NUMBER 1003867 ANNUAL REPORT (CONTINUED) FOR THE YEAR ENDED 5[TH] APRIL 2024
Page 2.
Achievements and Performance (continued)
In addition the Trustees had made a grant during the year of £35,000 to a University of Newcastle study “ Researching Allied Health in Schools and Education”. This was a further study forming part of the BACD Funding Award. This award, of up to £35,000 per annum, has a further three years to run.
The year in question finished with the very sad news that Martin Bax passed away on 24 March. Martin had been a Trustee of the Foundation for 20 years and made a significant contribution to the field of neurology and childhood neurodisabilty, sitting on the boards of many national and internation organisations. Martin had been a major driving force behind the success of the Foundation until his retirement in October 2014
The Trust is not dependent upon the services of unpaid volunteers or donations-in-kind.
Public Benefit
The Trustees have considered their duty set out in Section 17 of the Charities Act 2011 to have due regard to public benefit guidance published by the Commission, and in their opinion the foregoing report on the achievements and performance demonstrates that they have complied therewith.
Financial Review
Going concern
The Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.
Results for the year
Unrestricted income for the year amounted to £81,756, all of which was from investment activities. Unrestricted resources expended during the year amounted to £137,575, of which £122,987 was in respect of funding research projects and £8,206 for the associated support costs.
Reserves Policy
The Trustees’ general reserve policy is to maintain sufficient in the income fund to cover commitments to research projects, (both in progress and agreed to in principle) and to ensure the smooth running of the day to day operations of the Trust. However, no strict reserve policy is necessary as the Trustees are permitted under the Trust Deed to spend Capital. The level of reserves and current commitments are reviewed regularly at Trustees’ meetings.
At the ended of the year, the total unrestricted funds amounted to £1,722,410 and total restricted funds were £45,814.
Governance, Structure and Management
Governance
In terms of civil law the operation of the Trust is governed by its Trust Deed through the Trustees and is a Charity registered with the Charity Commission for England and Wales (Charity Registration Number 1003867).
Structure and Management
Ian Burman acts as Clerk to the Trustees and deals with all general administration. Abigale Page acts as Treasurer and deals with the maintenance of the accounting records. Any policy decisions are taken by the full Board of Trustees. There were no changes in policy during the year.
Risk Management
The Trustees continue to monitor the major risks to which the Trust is exposed and are satisfied that adequate systems are in place to mitigate the exposure to those risks.
Recruitment and appointment of new trustees
The power of appointing new or additional Trustees is vested in the Trustees, who prior to appointment would be introduced to the workings of the Trust and advised of their joint and several responsibilities.
H. & M. CASTANG CHARITABLE TRUST CHARITY NUMBER 1003867 ANNUAL REPORT (CONTINUED) FOR THE YEAR ENDED 5[TH] APRIL 2024
Page 3.
Trustees
Michael Boyde Glynn FCA – Retired 17[th] January 2024 Ian Anthony Burman LLB Dr Paul Eunson Dr Jeremy Parr Abigail Page FCA
Working Name
Castang Foundation
Registered Office
Pinners Hall, 105-108 Old Broad Street, London, EC2N 1ER.
Accounting Records Maintained at
20 Eversley Road, Bexhill-on-Sea, East Sussex, TN40 1HE.
Solicitors
Laytons Solicitors LLP, Pinners Hall, 105-108 Old Broad Street, London, EC2N 1ER.
Bankers
National Westminster Bank plc., 9 Devonshire Road, Bexhill-on-Sea, East Sussex, TN40 1AG.
Stockbrokers
Charles Stanley & Company Limited, 25 Luke Street, London, EC2A 4AR.
Accountants
Gibbons Mannington & Phipps LLP, 20 Eversley Road, Bexhill-on-Sea, East Sussex, TN40 1HE.
Independent Examiner
Andy Childs FCA, Magee Gammon, Henwood House, Henwood, Ashford, Kent, TN24 8DH.
Web Site
www.castangfoundation.org.uk
On behalf of the Trustees:
Ian A. Burman
13th November 2024
Page 4.
H. & M. CASTANG CHARITABLE TRUST STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 5TH APRIL 2024
| Income Capital Notes Fund Fund £ £ Income and endowments from: Investments Dividends received on equities 17 53,773 Interest received on other Investments 18 12,929 Interest received on fixed interest stocks 19 14,540 Stockbrokers account interest 514 Total income 81,756 0 Expenditure on: Raising funds 6 15,416 Charitable activities 2 137,575 Total expenditure 137,575 15,416 Net income/(expenditure) (55,819) (15,416) Transfer between funds 0 0 (55,819) (15,416) Gains/(losses) on investment assets Unrealised 17-19 (51,438) Realised 17-19 (741) 0 (52,179) Net Movement In Funds (55,819) (67,595) Reconciliation of Funds Total Funds brought forward 269,823 1,576,001 Total Funds carried forward 214,004 1,508,406 Unrestricted Funds |
Restricted Fund £ 0 0 0 0 0 0 45,814 45,814 |
Total 2024 £ 53,773 12,929 14,540 514 81,756 15,416 137,575 152,991 (71,235) 0 (71,235) (51,438) (741) (52,179) (123,414) 1,891,638 1,768,224 |
Total 2023 £ 53,421 9,996 13,163 351 |
|---|---|---|---|
| 76,931 | |||
| 10,731 64,672 |
|||
| 75,403 | |||
| 1,528 0 |
|||
| 1,528 | |||
| (85,910) (6,011) |
|||
| (91,921) | |||
| (90,393) 1,982,031 |
|||
| 1,891,638 |
H. & M. CASTANG CHARITABLE TRUST BALANCE SHEET AS AT 5TH APRIL 2024
Page 5.
| Notes 2024 £ £ Fixed assets Investments: Equities 17 1,163,642 Fixed income stocks 18 192,290 Other investments 19 325,831 1,681,763 Current assets Debtors 11 0 Cash at bank and with stockbrokers 88,467 Total Current assets 88,467 Liabilities Creditors: Amounts falling due within one year 12 2,006 Net Current assets 86,461 Net assets 1,768,224 The funds of the charity: 13 Unrestricted funds: Capital fund 1,508,406 Income fund 214,004 Restricted fund 45,814 Total charity funds 1,768,224 |
Notes 2024 £ £ Fixed assets Investments: Equities 17 1,163,642 Fixed income stocks 18 192,290 Other investments 19 325,831 1,681,763 Current assets Debtors 11 0 Cash at bank and with stockbrokers 88,467 Total Current assets 88,467 Liabilities Creditors: Amounts falling due within one year 12 2,006 Net Current assets 86,461 Net assets 1,768,224 The funds of the charity: 13 Unrestricted funds: Capital fund 1,508,406 Income fund 214,004 Restricted fund 45,814 Total charity funds 1,768,224 |
2023 £ £ 1,253,639 194,979 372,434 1,821,052 0 72,883 72,883 2,297 70,586 1,891,638 1,576,001 269,823 45,814 1,891,638 |
2023 £ £ 1,253,639 194,979 372,434 1,821,052 0 72,883 72,883 2,297 70,586 1,891,638 1,576,001 269,823 45,814 1,891,638 |
|---|---|---|---|
| 1,681,763 86,461 |
1,821,052 70,586 |
||
| 1,768,224 | 1,891,638 | ||
| 1,508,406 214,004 45,814 |
1,576,001 269,823 45,814 |
||
| 1,768,224 | 1,891,638 |
Approved by the Board of Trustees on 13th November 2024
Ian Burman Dr Jeremy Parr
Dr Paul Eunson
Abigail Page
Page 6.
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 5TH APRIL 2024
1. Accounting Policies
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention with the exception of investments which are included at market value.
Financial Reporting Standard 102 - reduced disclosure exemptions
The charity has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':
- the requirements of Section 7 Statement of Cash Flows
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probably that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources.
Taxation
The charity is exempt from tax on its charitable activities.
Cash at bank and with stockbrokers
Cash at bank and with stockbrokers includes cash and short term highly liquid investments with a short maturity of three months or less from the opening of the deposit.
Creditors
Creditors are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors are normally recognised at their settlement value.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
| 2. Charitable Activities Research projects Other costs Governance costs |
2024 £ 131,193 4,378 2,004 137,575 |
2023 £ 57,504 5,236 1,932 |
|---|---|---|
| 64,672 |
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 7.
| Research Projects NIHR Castang Foundation Advanced Fellowship Award Dr Alexandra Hendry, University of Oxford - Refining, testing and targeting an intervention to support the early development of Executive Functions amongst infants at elevated likelihood of autism and/or ADHD BACD Funding Award - RAISE: Researching Allied Health in Schools and Education Newcastle University Research staff and running costs Ian Crocker Study - A Heme-Binding Agent for the Prevention of Fetal Vascular Compromise Manchester University Support costs |
2024 £ 40,069 40,069 35,000 35,000 47,918 47,918 8,206 131,193 |
2023 £ 42,600 |
|---|---|---|
| 42,600 | ||
| 0 | ||
| 0 | ||
| 6,271 | ||
| 6,271 | ||
| 8,633 | ||
| 57,504 |
3. Research Projects
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 8.
| 5. Support costs Trustees' expenditure: Research into projects being considered by the Trustees and monitoring those supported by the charity Raising funds Governance costs Allocated as follows: Grants and research projects Raising funds Governance costs |
2024 £ 8,206 15,416 2,004 25,626 8,206 15,416 2,004 25,626 |
2023 £ 8,633 10,731 1,932 |
|---|---|---|
| 21,296 | ||
| 8,633 10,731 1,932 |
||
| 21,296 |
Support costs comprises of research into projects being considered by the Trustees and monitoring those supported by the Charity. Management and administration comprises of costs for the running of the Charity itself as an organisation. Where costs cannot be directly attributed to either of these two categories, it is estimated based on activity levels that 60% of legal costs and 40% of accountancy charges are attributable to support costs with the balance attributable to management and administration.
| 6. Raising funds Investment management costs: Stockbroker's nominee fees Administrative fees 7. Other costs Bank charges and interest Printing, stationery and website costs Management and administrative fees 8. Governance costs Accountancy charges Independent examiner's charges |
13,159 2,257 15,416 16 144 4,218 4,378 1,020 984 2,004 |
8,321 2,410 |
|---|---|---|
| 10,731 | ||
| 12 388 4,836 |
||
| 5,236 | ||
| 996 936 |
||
| 1,932 |
9. Related party transactions
Transactions with Trustees
I.A. Burman Esq. is a partner in Laytons Solicitors LLP, the Trust's Solicitors, and benefits from the fees paid to that firm for legal and other duties. The total fees payable during the year were £7,590. At the year end there was no balance owing to Laytons Solicitors LLP.
A.M. Page is a Partner in Gibbons Mannington & Phipps LLP, the Trust's Accountants. The total fees payable for bookkeeping and accountancy services during the year were £7,416 At the year end there was a balance owed to Gibbons Mannington & Phipps LLP of £1,020.
Clause 14 of the Trust Deed permits remuneration to be paid to Trustees acting in a professional capacity and Paragraph 17 of the First Schedule to the Trust Deed permits reimbursement of Trustees expenses.
Other transactions
Glynn designs is a web design business owned by I. Glynn who is the son of M.B. Glynn. During the year payments totaling £144 were made to the business for web design and hosting fees.
Expenses
Expenses were reimbursed to two trustees for travel expenses during the year of £695.
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 9.
| 10. Investments Equities Quoted investments £ (see notes 17,18 & 19) Market value at 6th April 2023 1,253,639 Additions during the year 0 Disposals during the year (45,747) Net unrealised investment gains/(losses) (44,250) Market value at 5th April 2024 1,163,642 Historical cost as at 5th April 2024 839,371 11. Debtors Other debtors 12. Creditors: Amounts falling due within one year Other creditors 13. Statement of funds Balance at Incoming 06.04.2023 Resources £ £ Unrestricted funds Income fund General 269,823 81,756 Capital Fund 1,576,001 0 1,845,824 81,756 Restricted funds BACD fund 45,814 0 45,814 0 Total funds 1,891,638 81,756 |
10. Investments Equities Quoted investments £ (see notes 17,18 & 19) Market value at 6th April 2023 1,253,639 Additions during the year 0 Disposals during the year (45,747) Net unrealised investment gains/(losses) (44,250) Market value at 5th April 2024 1,163,642 Historical cost as at 5th April 2024 839,371 11. Debtors Other debtors 12. Creditors: Amounts falling due within one year Other creditors 13. Statement of funds Balance at Incoming 06.04.2023 Resources £ £ Unrestricted funds Income fund General 269,823 81,756 Capital Fund 1,576,001 0 1,845,824 81,756 Restricted funds BACD fund 45,814 0 45,814 0 Total funds 1,891,638 81,756 |
Equities £ 1,253,639 0 (45,747) (44,250) |
Fixed Income Stocks £ 194,979 0 0 (2,689) |
Other Investments £ 372,434 0 (42,104) (4,499) |
Total 2024 £ 1,821,052 0 (87,851) (51,438) |
Total 2023 £ 1,941,711 60,005 (94,754) (85,910) |
|---|---|---|---|---|---|---|
| 1,163,642 | 192,290 | 325,831 | 1,681,763 | 1,821,052 | ||
| 839,371 | 206,481 | 247,104 | 1,292,956 | 1,347,378 | ||
| Resources Expended £ (137,575) (15,416) |
Net gains/ (losses) 0 (52,179) |
2024 £ 0 |
2023 £ 0 |
|||
| 2,006 | 2,297 | |||||
| Transfers £ 0 0 |
Balance at 05.04.2024 £ 214,004 1,508,406 |
|||||
| 1,845,824 | 81,756 | (152,991) | (52,179) | 0 | 1,722,410 | |
| 45,814 | 0 | 0 | 0 | 0 | 45,814 | |
| 45,814 | 0 | 0 | 0 | 0 | 45,814 | |
| 1,891,638 | 81,756 | (152,991) | (52,179) | 0 | 1,768,224 |
Details of restricted funds are as follows:
The BACD fund consist of a grant of £180,000 which will be expended on research projects. To date £169,186 has been expended.
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 10.
14. Future Commitments
| Future Commitments The Trustees have agreed to fund the following projects: a. BACD b. BACD (Restricted) c. University of Manchester - Ian Crocker Study d. NIHR Castang Foundation Advanced Fellowship Award |
Total Cost £ 175,000 180,000 165,665 190,101 |
Future at 5.4.24 £ 140,000 45,814 4,641 76,339 Commitment |
|---|---|---|
| 266,794 |
BACD
The Foundation has agreed a commitment of £175,000 to support research projects put forward by the British Academy of Childhood Disability (BACD).
This commitment will be paid over 5 years between 2023 and 2027 with £35,000 paid per annum.
BACD - Restricted
BACD made a grant of £180,000 which will be expended on research projects. There is a balance of £45,814 and the trustees are currently seeking a new project to allocate these fund to.
University of Manchester - Ian Crocker Study
The Foundation agreed to fund the cost of the study by Ian Crocker with the University of Manchester - Heme binding agent for the prevention of fetal vascular compromise. This is a three year project costing £165,665. Donations of £161,024 have already been made towards this study and a further donation of £25,000 has been made from another charity. The balance remaining is £4,641.
NIHR Castang Foundation Advanced Fellowship Award
The Foundation is working in partnership with the National Institute for Health Research (NIHR) Academy and is co-funding an NIHR Castang Foundation Advanced Fellowship Award. This has been awarded to Dr Alexandra Hendry at the University of Oxford to fund research into 'Refining, testing and targeting an intervention to support the early development of Executive Functions amongst infants at elevated likelihood of autism and/or ADHD'. This funding commenced during 2021/22 and the total cost to the Foundation is £190,101 over five years.
15. Analysis of net assets between funds
| Fixed asset investments Current assets Creditors |
Income Capital Fund Fund £ £ 173,357 1,508,406 42,653 0 (2,006) 0 214,004 1,508,406 Unrestricted Funds |
Restricted Funds £ 0 45,814 0 45,814 |
Total funds 2024 £ 1,681,763 88,467 (2,006) 1,768,224 |
Total funds 2023 £ 1,821,052 72,883 (2,297) |
|---|---|---|---|---|
| 1,891,638 |
H. & M. CASTANG CHARITABLE TRUST
Page 11.
NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
16. Comparative Statement of Financial Activities
| Income and endowments from: Investments Dividends received on equities Interest received on other Investments Interest received on fixed interest stocks Stockbrokers account interest Total income Expenditure on: Raising funds Charitable activities Total expenditure Net income/(expenditure) Transfer between funds Gains/(losses) on investment assets Unrealised Realised Net Movement In Funds Reconciliation of Funds Total Funds brought forward Total Funds carried forward |
Income Capital Fund Fund £ £ 53,421 9,996 13,163 351 76,931 0 10,731 64,672 64,672 10,731 12,259 (10,731) 12,259 (10,731) (85,910) (6,011) 0 (91,921) 12,259 (102,652) 257,564 1,678,653 269,823 1,576,001 Unrestricted Funds |
Restricted Fund £ 0 0 0 0 0 0 45,814 45,814 |
Total 2023 £ 53,421 9,996 13,163 351 |
|---|---|---|---|
| 76,931 | |||
| 10,731 64,672 |
|||
| 75,403 | |||
| 1,528 0 |
|||
| 1,528 | |||
| (85,910) (6,011) |
|||
| (91,921) | |||
| (90,393) 1,982,031 |
|||
| 1,891,638 |
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 12.
17. Investments - Equities
| At 6th April 2023 Acquisitions Sa Market Held within the U.K. Number Value Number Cost Number £ £ AstraZeneca Ordinary 25p Shares 700 81,158 19.05.2023 130 BAE Systems Ordinary 2.5p Shares 8,500 84,575 19.05.2023 1,500 British American Tobacco Ord 25p shares 1,870 52,454 BP Ordinary 0.25US$ Shares 12,000 64,044 Diageo Ordinary 28101/108p Shares 2,000 73,380 Digital 9 Infrastructure Ord NPV 38,095 25,828 Foresight Solar Fund Ltd NPV 40,000 44,160 GSK Ordinary 25p Shares 4,000 59,488 Impact Healthcare Reit Ordinary 1p shares 38,000 35,340 JPMorgan Global Core Real Assets Ord NPV 40,000 34,240 Land Securities Ordinary 10.6666666p Shares 4,570 28,197 Carried forward 582,864 0 |
les Proceeds £ 15,428 14,665 |
Realised Gains/ (Losses) £ 356 (260) |
Unrealised A Gains/ (Losses) Number £ (5,552) 570 23,170 7,000 (8,902) 1,870 (3,312) 12,000 (16,390) 2,000 (17,219) 38,095 (11,080) 40,000 5,692 4,000 (3,420) 38,000 (7,040) 40,000 663 4,570 (43,390) |
t 5th April 202 Market Value £ 60,534 92,820 43,552 60,732 56,990 8,609 33,080 65,180 31,920 27,200 28,860 |
4 Historical Cost Date £ Sep 17,260 Mar Jun 31,120 Nov May 50,235 Aug Nov Feb Jun 51,597 Sep Dec Mar Apr 12,840 Oct 40,275 Jun May 39,949 Aug Nov Feb Apr Jul 63,143 Oct Jan May 39,599 Sep Nov Feb May 40,275 Aug Nov Feb Apr 24,094 Jul Oct Jan 410,387 |
Dividend Received £ 409.26 889.20 1,411.00 805.00 1,079.36 1,079.36 1,079.36 1,079.36 637.07 687.84 688.40 683.06 616.60 983.40 571.43 712.00 752.00 758.00 752.00 550.00 560.00 560.00 560.00 643.15 643.15 643.15 643.15 420.00 420.00 420.00 420.00 411.30 548.40 411.30 420.44 |
|---|---|---|---|---|---|---|
| 30,093 | 96 | 509,477 | 23,947.74 |
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 13.
17. Investments - Equities (Continued)
| At 6th April 2023 Acquisitions S Market Held within the U.K. Number Value Number Cost Number £ £ Brought forward 582,864 0 Legal & General Ordinary 2½p Shares 24,000 56,352 M.P. Evans Group Ordinary 10p Shares 3,600 31,680 PRS Reit (The) Ordinary 1p shares 29,205 23,685 RELX Group Ordinary 14 51/116p Shares 3,400 89,250 19.05.2023 600 SDCL Energy Efficiency Income Trust Ordianry 1p shares 40,000 34,320 Shell Ordinary Euro 0.7 3,000 70,890 Supermarket Income REIT Ordinary 1p Shares 36,000 30,456 Unilever Ordinary 31/9p Shares 1,700 72,905 Vodafone Ordinary US$0.2095238 29,000 25,940 shares Held Outside the U.K. Roche Holdings AG Genusscheine NPV (NES) 300 71,189 Samarang Asset Management S.A. Asian Prosperity A1 143 37,698 Schroder Oriental Ordinary 1p Shares 35,000 89,600 Universal Music Group 1,850 36,810 Euro 10 shares 1,253,639 0 |
ales Proceeds £ 30,093 14,864 |
Realised Gains/ (Losses) £ 96 (886) |
Unrealised A Gains/ (Losses) Number £ (43,390) 3,912 24,000 (2,016) 3,600 (905) 29,205 19,404 2,800 (10,720) 40,000 12,510 3,000 (3,168) 36,000 (7,676) 1,700 (6,052) 29,000 (13,296) 300 (854) 143 1,050 35,000 6,951 1,850 (44,250) |
t 5th April 2024 Market Value £ 509,477 60,264 29,664 22,780 92,904 23,600 83,400 27,288 65,229 19,888 57,893 36,844 90,650 43,761 |
Historical Cost Date £ 410,387 Jun 34,670 Sep Jun 29,454 Nov May 29,426 Sep Nov Mar Jun 18,118 Sep Jun 40,677 Sep Dec Mar Jun Sep 39,095 Dec Mar May 37,161 Aug Nov Feb Jun 15,457 Aug Dec Mar Aug 45,233 Feb 30,374 Mar 41,042 Dec May Aug 37,726 Nov Feb Jun 30,551 Oct 839,371 |
Dividend Received £ 23,947.74 3,343.20 1,370.40 1,080.00 450.00 292.05 292.05 292.06 292.06 1,322.60 476.00 600.00 624.00 624.00 624.00 689.70 783.60 789.30 807.00 540.00 540.00 545.40 545.40 643.11 629.00 631.55 619.99 1,120.47 1,115.12 1,644.28 1,681.68 700.00 700.00 2,030.00 700.00 362.04 325.35 |
|---|---|---|---|---|---|---|
| 44,957 | (790) | 1,163,642 | 53,773.15 |
H. & M. CASTANG CHARITABLE TRUST NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 5TH APRIL 2024
Page 14.
18. Investments - Fixed Income Stocks
| At 6th April | 2023 | Acquisitions | Acquisitions | Sales | Sales | Realised | Unrealised | At 5th | April 2024 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market | Gains/ | Gains/ | Market | Historical | Income | |||||||||||
| Held within the U.K. | Number | Value | Number | Cost | Number | Proceeds | (Losses) | (Losses) | Number | Value | Cost | Date | Received | |||
| £ | £ | £ | £ | £ | £ | £ | £ | £ | £ | £ | £ | |||||
| CG Portfiolio Fund | ||||||||||||||||
| The Dollar Fund CLS 'D' | 300 | 49,983 | (2,562) | 300 | 47,421 | 48,186 | Nov | 886.52 | ||||||||
| CQS New City High Yield Fund Ltd | May | 1,000.00 | ||||||||||||||
| Ordinary Shares | 100,000 | 48,650 | 2,950 | 100,000 | 51,600 | 52,388 | Aug | 1,490.00 | ||||||||
| Nov | 1,000.00 | |||||||||||||||
| Feb | 1,000.00 | |||||||||||||||
| GCP Infrastructure Investments Ltd | Jun | 267.59 | ||||||||||||||
| Ordinary C £0.01 | 15,291 | 13,227 | (2,325) | 15,291 | 10,902 | 16,095 | Sep | 267.59 | ||||||||
| Dec | 267.59 | |||||||||||||||
| Mar | 267.59 | |||||||||||||||
| Invesco Bond Income Plus | May | 862.50 | ||||||||||||||
| Ordinary NPV | 30,000 | 49,125 | 2,475 | 30,000 | 51,600 | 55,147 | Aug | 862.50 | ||||||||
| Nov | 862.50 | |||||||||||||||
| Feb | 862.50 | |||||||||||||||
| Held Outside the U.K. | ||||||||||||||||
| Biopharma Credit | Apr | 1,157.61 | ||||||||||||||
| Ord USD0.01 Shares | 44,000 | 33,994 | (3,227) | 44,000 | 30,767 | 34,665 | May | 602.51 | ||||||||
| Sep | 597.09 | |||||||||||||||
| Jan | 1,275.85 | |||||||||||||||
| Mar | 1,010.33 | |||||||||||||||
| 194,979 | 0 | 0 | 0 | (2,689) | 192,290 | 206,481 | 14,540.27 | |||||||||
| **19. ** | Investments - Other | |||||||||||||||
| At 6th April | 2023 | Acquisitions | Sales | Realised | Unrealised |
At 5th | April 2024 | |||||||||
| Market | Gains/ | Gains/ | Market | Historical | Dividend | |||||||||||
| Held within the U.K. | Number | Value | Number | Cost | Number | Proceeds | (Losses) | (Losses) | Number | Value | Cost | Date | Received | |||
| £ | £ | £ | £ | £ | £ | £ | £ | |||||||||
| Bny Mellon Managers Ltd | Sep | 605.17 | ||||||||||||||
| Real Return | 39,000 | 42,104 | 01.03.2024 | 39,000 | 42,153 | 49 | Feb | 619.37 | ||||||||
| Charities Property Fund | May | 705.05 | ||||||||||||||
| Income Shares | 50,000 | 63,190 | (3,785) | 50,000 | 59,405 | 60,120 | Aug | 758.60 | ||||||||
| Nov | 736.10 | |||||||||||||||
| Feb | 1,655.65 | |||||||||||||||
| Ruffer Investment Company | Oct | 396.00 | ||||||||||||||
| Red Ptg Pref .0001p Shares | 24,000 | 74,160 | (9,960) | 24,000 | 64,200 | 30,814 | Mar | 480.00 | ||||||||
| Held Outside the U.K. | ||||||||||||||||
| Trojan Investments Funds | Jun | 1,012.52 | ||||||||||||||
| Trojan Global Income O Inc | 78,000.00 | 98,888 | 27.06.2023 | (513.49) | 0 | (1,162) | 77,486.51 | 97,726 | 89,342 | Oct | 612.61 | |||||
| Transfer to different security | Jan | 792.30 | ||||||||||||||
| Mar | 676.61 | |||||||||||||||
| Veritas Fund | Apr | 861.52 | ||||||||||||||
| Global Equity Income Sterling | 400 | 94,092 | 10,408 | 400 | 104,500 | 66,828 | Oct | 2,155.68 | ||||||||
| Apr | 861.52 | |||||||||||||||
| 372,434 | 0 | 42,153 | 49 | (4,499) | 325,831 | 247,104 | 12,928.70 |
INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES OF H. & M. CASTANG CHARITABLE TRUST FOR THE YEAR ENDED 5TH APRIL 2024
Page 15
I report on the accounts for the year ended 5th April 2024 set out on pages 4 to 14.
Respective responsibilities of trustees and examiner
The charity's trustees are responsible for the preparation of the accounts. The charity’s trustees consider that an audit is not required for this year (under section 144(2) of the Charities Act 2011 (the 2011 Act)) and that an independent examination is required.
It is my responsibility to
-
examine the accounts under section 145 of the 2011 Act,
-
to follow the procedures laid down in the General Directions given by the Charity Commission (under section 145(5)(b) of the 2011 Act), and
-
to state whether particular matters have come to my attention.
Basis of the independent examiner’s report
My examination was carried out in accordance with General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a “true and fair view” and the report is limited to those matters set out in the statement below.
Independent examiner's statement
In connection with my examination, no matter has come to my attention:
-
which gives me reasonable cause to believe that in, any material respect the requirements:
-
to keep accounting records in accordance with section 130 of the 2011 Act; and
-
to prepare accounts which accord with the accounting records and comply with the
-
Accounting requirements of the 2011 Act
have not been met; or
- to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.
Andy Childs FCA Magee Gammon Henwood House Henwood Ashford, Kent TN24 8DH
29th November 2024